cipemastat   Click here for help

GtoPdb Ligand ID: 6466

Synonyms: Ro 28-2653
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Cipemastat is a selective matrix metalloproteinase-1 inhibitor.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 110.26
Molecular weight 436.27
XLogP 1.44
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES ONC(=O)C(C(C(=O)N1CCCCC1)CC1CCCC1)CN1C(=O)N(C(C1=O)(C)C)C
Isomeric SMILES ONC(=O)[C@H]([C@H](C(=O)N1CCCCC1)CC1CCCC1)CN1C(=O)N(C(C1=O)(C)C)C
InChI InChI=1S/C22H36N4O5/c1-22(2)20(29)26(21(30)24(22)3)14-17(18(27)23-31)16(13-15-9-5-6-10-15)19(28)25-11-7-4-8-12-25/h15-17,31H,4-14H2,1-3H3,(H,23,27)/t16-,17+/m1/s1
InChI Key GFUITADOEPNRML-SJORKVTESA-N
References
1. Close DR. (2001)
Matrix metalloproteinase inhibitors in rheumatic diseases.
Ann Rheum Dis, 60 Suppl 3: iii62-7. [PMID:11890658]
2. Hemmings FJ, Farhan M, Rowland J, Banken L, Jain R. (2001)
Tolerability and pharmacokinetics of the collagenase-selective inhibitor Trocade in patients with rheumatoid arthritis.
Rheumatology (Oxford), 40 (5): 537-43. [PMID:11371662]
3. Lein M, Jung K, Ortel B, Stephan C, Rothaug W, Juchem R, Johannsen M, Deger S, Schnorr D, Loening S et al.. (2002)
The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat model.
Oncogene, 21 (13): 2089-96. [PMID:11960381]